Imperial College London
Portrait Picture

Simon Erridge

Faculty of Medicine, Department of Surgery & Cancer

Research Postgraduate
 
 
 
//

Contact

 

simon.erridge12

 
 
//

Location

 

Block B Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Kamocka:2021:10.1016/j.soard.2021.06.002,
author = {Kamocka, A and Parmar, C and Kurzatkowski, K and Chidambaram, S and Goh, EL and Erridge, S and Small, P and Purkayastha, S and McGlone, ER and Khan, O and NBSR, Committee},
doi = {10.1016/j.soard.2021.06.002},
journal = {Surgery for Obesity and Related Diseases},
pages = {1732--1738},
title = {Outcomes of bariatric surgery in extreme obesity: results from the United Kingdom National Bariatric Surgery Registry for patients with a body mass index >70 kg/m2},
url = {http://dx.doi.org/10.1016/j.soard.2021.06.002},
volume = {17},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BACKGROUND: Bariatric and metabolic surgery (BMS) is an established safe, effective, and durable treatment for obesity and its complications. However, there is still a paucity of evidence on surgery outcomes in patients suffering from extreme obesity. OBJECTIVES: This study aimed to evaluate outcomes of BMS in weight loss and the resolution of co-morbidities in patients with a body mass index (BMI) ≥70kg/m2. SETTING: National Health Service and private hospitals in the United Kingdom. METHODS: This cohort study analyzed prospectively collected records from the UK National Bariatric Surgery Registry of patients with a BMI ≥70 kg/m2 undergoing Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or adjustable gastric band (AGB) between January 2009 and June 2014. RESULTS: There were 230 patients (64% female) eligible for inclusion in the study: 22 underwent AGB; 102 underwent SG, and 106 underwent RYGB. Preoperative weight and BMI values were comparable (76 ± 7 kg/m2 for AGB; 75 ± 5 kg/m2 for SG; 74 ± 5 kg/m2 for RYGB). The median postoperative follow-up was 13 months for AGB (10-22 mo), 18 for SG (6-28 mo), and 15 for RYGB (6-24 mo). Patients undergoing RYGB and SG exhibited the greatest postoperative total body weight loss (35 ± 13% and 31 ± 15%, respectively; P = .14), which led to postoperative BMIs of 48 ± 10 kg/m2 and 51 ± 11 kg/m2, respectively (P = .14). All procedures conferred a reduction in the incidence of co-morbidities, including type 2 diabetes, and led to improved functional statuses. The overall complication rate was 7%, with 3 deaths (1%) within 30 days of surgery. CONCLUSION: This study found that primary BMS in patients with a BMI >70kg/m2 has an acceptable safety profile and is associated with good medium-term clinical outcomes. RYGB and SG are associated with better weight loss and great improvements in co-morbidities than AGB. Given the noninferiority of SG outcomes and SG'
AU  - Kamocka,A
AU  - Parmar,C
AU  - Kurzatkowski,K
AU  - Chidambaram,S
AU  - Goh,EL
AU  - Erridge,S
AU  - Small,P
AU  - Purkayastha,S
AU  - McGlone,ER
AU  - Khan,O
AU  - NBSR,Committee
DO  - 10.1016/j.soard.2021.06.002
EP  - 1738
PY  - 2021///
SN  - 1550-7289
SP  - 1732
TI  - Outcomes of bariatric surgery in extreme obesity: results from the United Kingdom National Bariatric Surgery Registry for patients with a body mass index >70 kg/m2
T2  - Surgery for Obesity and Related Diseases
UR  - http://dx.doi.org/10.1016/j.soard.2021.06.002
UR  - https://www.ncbi.nlm.nih.gov/pubmed/34266776
UR  - https://www.sciencedirect.com/science/article/pii/S1550728921002902?via%3Dihub
UR  - http://hdl.handle.net/10044/1/103474
VL  - 17
ER  -
Download